Immune Cell-Mediated Autoimmune Responses in Severe Asthma

키워드

참고문헌 (80)

1. Song P, "Global, regional, and national prevalence of asthma in 2019 : a systematic analysis and modelling study", J Glob Health, 12, pp.04052~ (2022)
2. Carr TF, "Eosinophilic and noneosinophilic asthma", Am J Respir Crit Care Med, 197, pp.22~37 (2018)
3. Salter B, "Biologics in asthma : a molecular perspective to precision medicine", Front Pharmacol, 12, pp.793409~ (2022)
4. "2022 GINA report, global strategy for asthma management and prevention"[URL]
5. Mukherjee M, "Airway autoimmune responses in severe eosinophilic asthma following low-dose mepolizumab therapy", Allergy Asthma Clin Immunol, 13, pp.2~ (2017)
6. Mukherjee M, "Sputum autoantibodies in patients with severe eosinophilic asthma", J Allergy Clin Immunol, 141, pp.1269~1279 (2018)
7. Mukherjee M, "Autoimmune responses in severe asthma", Allergy Asthma Immunol Res, 10, pp.428~447 (2018)
8. Mukherjee M, "Glucocortiosteroid subsensitivity and asthma severity", Curr Opin Pulm Med, 23, pp.78~88 (2017)
9. McDowell PJ, "Clinical remission in severe asthma with biologic therapy : an analysis from the UK severe asthma registry", Eur Respir J, 62, pp.2300819~ (2023)
10. Hansen S, "Clinical response and remission in patients with severe asthma treated with biologic therapies", Chest, 165, pp.253~266 (2023)
11. Mukherjee M, "Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena", Eur Respir J, 56, pp.2000117~ (2020)
12. Sánchez J, "Immunoglobulin E and G autoantibodies against eosinophil proteins in children and adults with asthma and healthy subjects", World Allergy Organ J, 16, pp.100742~ (2023)
13. Lee DH, "Epithelial autoantigenspecific IgG antibody enhances eosinophil extracellular trap formation in severe asthma", Allergy Asthma Immunol Res, 14, pp.479~493 (2022)
14. Choi Y, "Neutrophil extracellular DNA traps induce autoantigen production by airway epithelial cells", Mediators Inflamm, 2017, pp.5675029~ (2017)
15. Mackay IR, "Tolerance and autoimmunity", West J Med, 174, pp.118~123 (2001)
16. Heinzmann A, "Genes for atopy and asthma", Curr Opin Allergy Clin Immunol, 1, pp.387~392 (2001)
17. Wan YI, "Genome-wide association study to identify genetic determinants of severe asthma", Thorax, 67, pp.762~768 (2012)
18. Moffatt MF, "A large-scale, consortium-based genomewide association study of asthma", N Engl J Med, 363, pp.1211~1221 (2010)
19. Kreiner E, "Shared genetic variants suggest common pathways in allergy and autoimmune diseases", J Allergy Clin Immunol, 140, pp.771~781 (2017)
20. Marzano AV, "Activation of blood coagulation in bullous pemphigoid : role of eosinophils, and local and systemic implications", Br J Dermatol, 160, pp.266~272 (2009)
21. Park S, "Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis : systematic review and meta-analysis", Am J Gastroenterol, 111, pp.1692~1701 (2016)
22. Messingham KN, "Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoid", PLoS One, 9, pp.e107725~ (2014)
23. Diny NL, "Eosinophils in autoimmune diseases", Front Immunol, 8, pp.484~ (2017)
24. Wigerblad G, "Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases", Nat Rev Immunol, 23, pp.274~288 (2023)
25. Gupta S, "The role of neutrophils and NETosis in autoimmune and renal diseases", Nat Rev Nephrol, 12, pp.402~413 (2016)
26. Sümegi A, "Glucocorticosteroid therapy decreases CD14-expression and CD14-mediated LPS-binding and activation of monocytes in patients suffering from systemic lupus erythematosus", Clin Immunol, 117, pp.271~279 (2005)
27. Peng A, "Elevated circulating CD14lowCD16+ monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization", Clin Exp Med, 16, pp.511~521 (2016)
28. Mathew J, "Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis", Histopathology, 25, pp.65~70 (1994)
29. Thiesen S, "CD14hiHLA-DRdim macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn’s disease", J Leukoc Biol, 95, pp.531~541 (2014)
30. Demetter P, "Colon mucosa of patients both with spondyloarthritis and Crohn’s disease is enriched with macrophages expressing the scavenger receptor CD163", Ann Rheum Dis, 64, pp.321~324 (2005)
31. Lee Y, "Longitudinal outcomes of severe asthma : real-world evidence of multidimensional analyses", J Allergy Clin Immunol Pract, 9, pp.1285~1294 (2021)
32. Choi Y, "Distinct functions of eosinophils in severe asthma with type 2 phenotype : clinical implications", Korean J Intern Med, 35, pp.823~833 (2020)
33. Choi Y, "Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma", Exp Mol Med, 50, pp.1~8 (2018)
34. Choi Y, "Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma", Allergy, 75, pp.95~103 (2020)
35. Tan NS, "A unique CD27-IgD-B cell population in the sputum of severe eosinophilic asthma associated with airway autoimmunity", Am J Respir Cell Mol Biol, 67, pp.506~511 (2022)
36. Qin R, "Sputum autoantibodies are more relevant in autoimmune responses in asthma than are serum autoantibodies", Allergy Asthma Immunol Res, 11, pp.406~421 (2019)
37. Esposito I, "Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma", Front Immunol, 14, pp.1164941~ (2023)
38. Ortega HG, "Mepolizumab treatment in patients with severe eosinophilic asthma", N Engl J Med, 371, pp.1198~1207 (2014)
39. Chen F, "Characteristics and role of neutrophil extracellular traps in asthma", Inflammation, 45, pp.6~13 (2022)
40. Moore WC, "Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis", J Allergy Clin Immunol, 133, pp.1557~1563 (2014)
41. Luu QQ, "Sputum antinuclear antibody serves as a biomarker for severe asthma", Allergy, 76, pp.3832~3835 (2021)
42. Nahm DH, "Identification of alpha-enolase as an autoantigen associated with severe asthma", J Allergy Clin Immunol, 118, pp.376~381 (2006)
43. Zuo Y, "Autoantibodies stabilize neutrophil extracellular traps in COVID-19", JCI Insight, 6, pp.e150111~ (2021)
44. Masucci MT, "The emerging role of neutrophil extracellular traps(NETs)in tumor progression and metastasis", Front Immunol, 11, pp.1749~ (2020)
45. Haegens A, "Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents", Eur Respir J, 31, pp.252~260 (2008)
46. Baines KJ, "Systemic upregulation of neutrophil α-defensins and serine proteases in neutrophilic asthma", Thorax, 66, pp.942~947 (2011)
47. Quoc QL, "S100A9in adult asthmatic patients : a biomarker for neutrophilic asthma", Exp Mol Med, 53, pp.1170~1179 (2021)
48. Lee TH, "Elevation of S100 calcium binding protein A9 in sputum of neutrophilic inflammation in severe uncontrolled asthma", Ann Allergy Asthma Immunol, 111, pp.268~275 (2013)
49. Pham DL, "Neutrophil autophagy and extracellular DNA traps contribute to airway inflammation in severe asthma", Clin Exp Allergy, 47, pp.57~70 (2017)
50. O’Byrne PM, "Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma : a randomised, double-blind, placebo-controlled trial", Lancet Respir Med, 4, pp.797~806 (2016)
51. Watz H, "Effects of the CXCR2 antagonist AZD5069 on lung neutrophil recruitment in asthma", Pulm Pharmacol Ther, 45, pp.121~123 (2017)
52. Mo Y, "Mesenchymal stem cells attenuate asthmatic inflammation and airway remodeling by modulating macrophages", monocytes in the IL-13-overexpressing mouse model, 2022, pp.22, e40~
53. Ma WT, "The role of monocytes and macrophages in autoimmune diseases : a comprehensive review", Front Immunol, 10, pp.1140~ (2019)
54. Son K, "Autoantibody-mediated macrophage dysfunction in patients with severe asthma with airway infections", Am J Respir Crit Care Med, 207, pp.427~437 (2023)
55. Grubczak K, "The role of different monocyte subsets and macrophages in asthma pathogenesis", Prog Health Sci, 5, pp.176~184 (2015)
56. Quoc QL, "Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma", Allergol Int, 73, pp.81~93 (2024)
57. Raundhal M, "High IFN-γ and low SLPI mark severe asthma in mice and humans", J Clin Invest, 125, pp.3037~3050 (2015)
58. Soyfoo MS, "Pathophysiologic role of interleukin-33", ST2 in Sjögren’s syndrome, 2021, pp.20, 102756~
59. Mavragani CP, "Activation of the type I interferon pathway in primary Sjogren’s syndrome", J Autoimmun, 35, pp.225~231 (2010)
60. Gauthier M, "Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias", JCI Insight, 2, pp.e94580~ (2017)
61. "Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT02794519, a phase 2a study to evaluate the effects of sirukumab in subjects with severe poorly controlled asthma; 2018 Aug 31"[URL]
62. Calverley PMA, "A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease", Respir Res, 18, pp.153~ (2017)
63. Esty B, "Treatment of severe persistent asthma with IL-6 receptor blockade", J Allergy Clin Immunol Pract, 7, pp.1639~1642 (2019)
64. Whetstone CE, "The role of airway epithelial cell alarmins in asthma", Cells, 11, pp.1105~ (2022)
65. Opitz B, "Innate immune recognition in infectious and noninfectious diseases of the lung", Am J Respir Crit Care Med, 181, pp.1294~1309 (2010)
66. Kang N, "Old and new damage-associated molecular patterns(DAMPs)in autoimmune diseases", Rheumatol Autoimmun, 2, pp.185~197 (2022)
67. Préfontaine D, "Increased expression of IL-33 in severe asthma : evidence of expression by airway smooth muscle cells", J Immunol, 183, pp.5094~5103 (2009)
68. Zhao R, "Elevated levels of interleukin-33 are associated with asthma : a meta-analysis", Immun Inflamm Dis, 11, pp.e842~ (2023)
69. Danieli MG, "Alarmins in autoimmune diseases", Autoimmun Rev, 21, pp.103142~ (2022)
70. Palmer G, "Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis", Arthritis Rheum, 60, pp.738~749 (2009)
71. Watanabe M, "Soluble ST2 enhances IL-33-induced neutrophilic and protype 2 inflammation in the lungs", Allergy, 77, pp.3137~3141 (2022)
72. Watanabe M, "Serum sST2 levels predict severe exacerbation of asthma", Respir Res, 19, pp.169~ (2018)
73. Awada A, "Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren’s syndrome", Ann Rheum Dis, 73, pp.1259~1263 (2014)
74. Kelsen SG, "Astegolimab(anti-ST2)efficacy and safety in adults with severe asthma : a randomized clinical trial", J Allergy Clin Immunol, 148, pp.790~798 (2021)
75. Crim C, "IL-33 receptor inhibition in subjects with uncontrolled asthma : a randomized, placebo-controlled trial", J Allergy Clin Immunol Glob, 1, pp.198~208 (2022)
76. Scheinecker C, "Treg cells in health and autoimmune diseases : new insights from single cell analysis", J Autoimmun, 110, pp.102376~ (2020)
77. Dembele M, "Tregitopes improve asthma by promoting highly suppressive and antigen-specific tregs", Front Immunol, 12, pp.634509~ (2021)
78. Collier JL, "Not-so-opposite ends of the spectrum : CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity", Nat Immunol, 22, pp.809~819 (2021)
79. Basler M, "Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome", Br J Pharmacol, 175, pp.38~52 (2018)
80. Galeotti C, "IVIG-mediated effector functions in autoimmune and inflammatory diseases", Int Immunol, 29, pp.491~498 (2017)

관련 논문AI추천